Cambridge, UK | Melbourne, Australia
www.inouyelab.org
Led by the always excellent @sritchie73.bsky.social with many wonderful contributors from around @cambridge-ceu.bsky.social academic.oup.com/eurheartj/ad...
Led by the always excellent @sritchie73.bsky.social with many wonderful contributors from around @cambridge-ceu.bsky.social academic.oup.com/eurheartj/ad...
tl;dr these next-gen risk factors could boost the number of CVD events prevented by +80% while keeping treatment efficiency (NNT) the same.
tl;dr these next-gen risk factors could boost the number of CVD events prevented by +80% while keeping treatment efficiency (NNT) the same.
Part of a long standing partnership with Cambridge and with plans to (hopefully) grow in exciting new research directions! baker.edu.au/who-we-are/o...
Part of a long standing partnership with Cambridge and with plans to (hopefully) grow in exciting new research directions! baker.edu.au/who-we-are/o...
tl;dr We identify protein vQTLs in multiple ancestries then use MVMR to show independent effects of mean & variance on disease, suggesting targeting protein variance could have therapeutic potential.
tl;dr We identify protein vQTLs in multiple ancestries then use MVMR to show independent effects of mean & variance on disease, suggesting targeting protein variance could have therapeutic potential.
A concern about PRSs is that clinicians lack genomics knowledge or risk-communication skills.
The solution is not to avoid PRSs, but to invest in training & support.
Read my paper with @mikeinouye.bsky.social 👉 rdcu.be/eNeKN
#Genomics
A concern about PRSs is that clinicians lack genomics knowledge or risk-communication skills.
The solution is not to avoid PRSs, but to invest in training & support.
Read my paper with @mikeinouye.bsky.social 👉 rdcu.be/eNeKN
#Genomics
A common claim: “The public won’t understand polygenic risk scores (PRSs)” — so using them in healthcare could be risky.
But is that really true? 🧵
A common claim: “The public won’t understand polygenic risk scores (PRSs)” — so using them in healthcare could be risky.
But is that really true? 🧵
Evidence so far doesn’t suggest substantial or lasting psychological harm — though research remains limited.
👉 rdcu.be/eNeKN
#Genomics #PolygenicRiskScores #Risk #MentalHealth #Depression #Anxiety
Evidence so far doesn’t suggest substantial or lasting psychological harm — though research remains limited.
👉 rdcu.be/eNeKN
#Genomics #PolygenicRiskScores #Risk #MentalHealth #Depression #Anxiety
and we are now recruiting PhD students for autumn 2026 @dphpc.bsky.social @cam.ac.uk - feel free to get in touch!
and we are now recruiting PhD students for autumn 2026 @dphpc.bsky.social @cam.ac.uk - feel free to get in touch!
Our results were surprising... 👉 www.medrxiv.org/content/10.1...
Our results were surprising... 👉 www.medrxiv.org/content/10.1...
Very cool results: Accumulating E with age reduces heritability & PGS effects
Led by Xilin Jiang (Wellcome ECR joint w/Alkes Price) + @arundurvasula.bsky.social
Very cool results: Accumulating E with age reduces heritability & PGS effects
Led by Xilin Jiang (Wellcome ECR joint w/Alkes Price) + @arundurvasula.bsky.social
There's never been a more exciting time to lead a research program in this area... and have work-life balance to boot!
There's never been a more exciting time to lead a research program in this area... and have work-life balance to boot!
You’d join an awesome institute in an incredible city (Melbourne, Australia) as well as partnerships like with @cam.ac.uk… you’ll also get to work with me 😁
You’d join an awesome institute in an incredible city (Melbourne, Australia) as well as partnerships like with @cam.ac.uk… you’ll also get to work with me 😁
You’d join an awesome institute in an incredible city (Melbourne, Australia) as well as partnerships like with @cam.ac.uk… you’ll also get to work with me 😁